The Findings Point to New Therapies for Dengue, West Nile and Ebola
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have shown for the first time how a previously unknown process works to promote infection in a number of dangerous viruses, including dengue, West Nile and Ebola.
The new study also points to a potential treatment, an experimental antibiotic that appears to inhibit infection by these deadly viruses, all of which lack vaccines and treatments.
The study, which was published recently by the journal Proceedings of the National Academy of Sciences (PNAS), was led by TSRI Associate Professor Hyeryun Choe.
“Most of these viruses use a specific molecule to enter cells,” Choe said. “In the new study, we were able to show how a second molecule plays a major and previously unknown role in that process. We also show an antibiotic called duramycin inhibits the actions of this molecule. This looks to be a promising broad-spectrum antiviral strategy and deepens our understanding of the entire infection process.”
Emerging Health Concern
The viruses in question belong to several families, including the flavivirus and filovirus families. Flaviviruses like dengue and West Nile viruses cause tens of thousands of deaths each year. Filoviruses like Ebola have emerged as major health concerns, particularly in tropical and subtropical areas such as the recent highly publicized Ebola outbreak in West Africa. Perhaps the greatest concern is dengue virus. More than one third of the world’s population is estimated to be at risk for dengue and more than 100 million people are estimated to be infected annually, according to recent studies.
The viruses take advantage of the process that normally occurs during programmed cell death or apoptosis. During this process, a lipid usually found on the inner side of the cell membranes, specifically phosphatidylserine (PS), shifts to the surface. Apoptosing cells are then recognized by PS receptors on phagocytes—cells that devour invading pathogens and dying cells—and engulfed by them.
When cells are dying from a virus infection, their freshly exposed PS is grabbed by the exiting virus and phagocytes engulf the virus. Once engulfed, the virus quickly turns the cell’s own biology on its head, forcing it to produce copies of the virus.
In the new study, Choe and her colleagues showed how another lipid known as phosphatidylethanolamine (PE), which is present on the viral surface, also contributes to the viral entry process.
“Despite the name, we found that PS receptors also detect PE, and viruses are able to take advantage of the abundance of PE on their surface,” said Audrey Stéphanie Richard, the first author of the study and a research associate in the Choe lab. “Through their PE, they latch onto the PS receptors on the host cell, taking control of the process and insuring entry and replication.”
Duramycin blocks viral entry into the cells by binding to the virus’s PE, preventing the virus from using it to latch onto the PS receptors on the cell. Duramycin, which is currently used as an imaging agent, binds specifically to PE.
Disrupting the relationship between these two molecules could open the door to new and novel antiviral strategies, potentially including duramycin and similar PE-inhibitors.
“This new study goes a long way in helping us understand how so-called PS receptors contribute to flavivirus and filovirus infections and how we can block them through the PE-binding compounds,” Choe said.
The Latest on: Viral Infections
[google_news title=”” keyword=”Viral Infections” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Viral Infections
- Ask A Doctor: How Can I Prevent Hepatitis C Infection?on February 26, 2024 at 11:10 pm
Expert opinion from Marcelle Freire Doctor of Medicine · 3 years of experience · Brazil Hepatitis C is a viral infection, chronic or acute, that attacks liver cells, causing changes in liver function.
- Vaping can increase susceptibility to infection by SARS-CoV-2on February 26, 2024 at 12:47 pm
CoV-2, the virus that spreads COVID-19 and continues to infect people around the world, a study by a research team at University of California, Riverside, has found.
- Long-term data reveals SARS-CoV-2 infection and vaccine-induced antibody responses are long-lastingon February 26, 2024 at 10:16 am
This investigation represents one of the most extensive and in-depth assessments of the longevity of SARS-CoV-2 immune responses to date. Its major conclusion is that changes in the virus that allow ...
- Measles outbreak in MP: Know symptoms, prevention tips, treatment of this viral infectionon February 24, 2024 at 7:34 am
Measles (rubeloa) is a viral disease that causes fever and a rash. It’s highly contagious and spreads through the air when a person with measles talks, coughs or sneezes.
- Potential gene targets for managing cassava whitefly, a viral diseases vector threatening food securityon February 23, 2024 at 4:00 am
Whiteflies, particularly the African cassava whitefly (Bemisia tabaci, SSA1-SG1), pose a significant threat to agricultural productivity in sub-Saharan Africa by transmitting viruses that cause ...
- ‘Persistent’ COVID infections may be creating new variants, study says. What to knowon February 22, 2024 at 9:03 am
One to three of every 100 COVID-19 infections are lasting more than one month, researchers said, allowing the virus to continue to mutate.
- One in two of us at risk of potentially deadly viral infection WHO announceson February 21, 2024 at 4:00 pm
The World Health Organisation has announced a 79 per cent jump in cases of the infection in the last year One in two of us will be at high or very high risk of getting measles by the end of the year, ...
- How to Tell the Difference Between Viral and Bacterial Tonsillitison February 19, 2024 at 4:00 pm
However, tonsillitis caused by a viral infection may be milder than tonsillitis caused by a bacterial infection. Tonsillitis is an inflammation of the tonsils — the two glands that sit in the ...
- Could viral infections over a lifetime influence Alzheimer’s risk?on February 16, 2024 at 2:15 am
Researchers have found that immune cells in the blood of people with Alzheimer's disease present epigenetic changes, which may be a result of previous viral infections, or other factors, such as ...
- Viral Infections: Race against dengueon February 15, 2024 at 5:17 am
Understanding the kinetics of dengue viruses in the bloodstream can provide insights into the clinical outcomes of the disease.
via Bing News